Appeal No. 94-3575 Application 07/929,044 REPRESENTATIVE CLAIM Claim 1, which is illustrative of the subject matter on appeal reads as follows: 1. In a transdermal therapeutic adhesive composition comprising an adhesive layer containing a pharmacologically active agent and adapted to adhere the composition to the skin, the improvement wherein the adhesion of the composition to the skin is provided by a polymer having lipophilic monomer units and hydrophilic monomer units in a weight ratio in the range from 98:2 to 0:100, wherein the composition has an adhesive strength of at least 25 g/12 mm and wherein the composition comprises 5 to 100 weight parts of a C -C alcohol, 0 to 50 weight parts of a 2 3 percutaneous absorption promoter and 10 to 40 weight parts of water, respectively based on 100 weight parts of the polymer. THE REFERENCES The prior art references relied on by the examiner are: Song et al. (Song) 4,789,547 Dec. 6, 1988 Petereit et al. (Petereit) 5,133,970 Jul. 28, 1992 Sablotsky et al. (Sablotsky) 5,186,938 Feb. 16, 1993 THE ISSUES The issues presented for review are: (1) Whether the examiner erred in finally rejecting claims 1 through 9, 11 through 19, 21, and 22 under 35 USC § 103 as 2Page: Previous 1 2 3 4 5 6 7 8 NextLast modified: November 3, 2007